Safety of anti‐IL‐23 risankizumab treatment in a patient with severe psoriasis and Charcot–Marie

登录注册会员服务联系我们

Safety of anti‐IL‐23 risankizumab treatment in a patient with severe psoriasis and Charcot–Marie–Tooth disease

Published:2023-09-12 Issue:4 Volume:64 Page:
ISSN:0004-8380
Container-title:Australasian Journal of Dermatology
language:en
Short-container-title:Aust J Dermatology

Author:

Carugno Andrea¹²^ORCID,Brigenti Noemi³,Gisondi Paolo³,Al Ghadban Zeina⁴,Parietti Michele¹^ORCID,Vezzoli Pamela¹^ORCID,Sena Paolo¹,Pisciotta Chiara⁵

Affiliation:

1. Dermatology Unit ASST Papa Giovanni XXIII Bergamo Italy

2. Ph.D. Program in Molecular and Translational Medicine (DIMET) University of Milan‐Bicocca Milan Italy

3. Department of Medicine, Section of Dermatology and Venereology University of Verona Verona Italy

4. School of Medicine and Surgery (SMS) University of Milan‐Bicocca Milan Italy

5. Department of Clinical Neurosciences Fondazione IRCCS Istituto Neurologico Carlo Besta Milan Italy

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajd.14154

Reference7 articles.

1. The Global, Regional, and National Burden of Psoriasis: Results and Insights From the Global Burden of Disease 2019 Study

2. EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 2: specific clinical and comorbid situations

3. Neurological Complications of Biological Treatment of Psoriasis

4. Etanercept for Psoriasis and Psoriatic Arthritis in a Patient with Charcot-Marie-Tooth Disease

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP